LAWRENCE, Mass.—NxStage Medical Inc. announced Feb. 23 that Elise A. Tordella has joined the company as vice president and general manager of critical care therapies.
In this position, Tordella will oversee NxStage's strategic growth initiatives to provide quality continuous renal replacement therapy (CRRT) solutions to the estimated U.S. $100 million critical care market opportunity.
"In addition to pioneering the home dialysis market with the System One, NxStage is an established leader in the critical care market, achieving an estimated 25 percent U.S. market share," said Joseph E. Turk, senior vice president, commercial operations, NxStage Medical. "The critical care market is a strategic component to our overall growth and profitability. We are delighted to have Elise Tordella on board. Her wealth of experience in sales and marketing for the medical device industry globally will drive efforts to deepen our penetration in the critical care dialysis market."
Tordella brings to NxStage more than 25 years of experience in multiple segments of the medical device industry, including renal, cardiology and general hospital products. Most recently, Tordella served as the vice president of global marketing for patient care at Covidien, a company that manufactures, distributes and services medical devices, pharmaceuticals and medical supplies.
"I am excited to join NxStage and be a part of a company that is making significant contributions to the dialysis community, specifically critical care patients," said Tordella. "I look forward to using my knowledge and experience in the medical device industry to help foster NxStage's continued growth in the critical care market and further enhance our value proposition to customers."
